| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/01/2001 | DE19935967A1 New DNA encoding Arabidopsis thaliana 1-deoxy-D-xylulose-5-phosphate reductoisomerase for identifying modulators of the enzyme that can be used as herbicides, antibiotic or anti-malarial agents |
| 02/01/2001 | DE19935113A1 Epoxidhydrolasen aus Streptomyces Epoxide hydrolases from Streptomyces |
| 02/01/2001 | DE19935105A1 DNA-Sequenzen, die Exportsysteme kodieren DNA sequences encoding export systems |
| 02/01/2001 | DE19935088A1 DNA-Sequenzen, die sich zum spezifischen Nachweis von Pseudomonas putida KT2440 eignen DNA sequences that are suitable for the specific detection of Pseudomonas putida KT2440 |
| 02/01/2001 | DE10031839A1 Erythropoietinkonjugate Erythropoietinkonjugate |
| 02/01/2001 | CA2696819A1 Ghrelin related peptides |
| 02/01/2001 | CA2693274A1 Peptide acceptor ligation methods |
| 02/01/2001 | CA2396591A1 Abc transport polynucleotides, polypeptides, and antibodies |
| 02/01/2001 | CA2383690A1 29 human secreted proteins |
| 02/01/2001 | CA2380540A1 Method for obtaining isogenic transgenic lines |
| 02/01/2001 | CA2380363A1 Method for conferring herbicide, pest, or disease resistance in plant hosts |
| 02/01/2001 | CA2380330A1 Method of correlating sequence function by transfecting a nucleic acid sequence of a donor organism into a plant host in an anti-sense or positive sense orientation |
| 02/01/2001 | CA2380317A1 Human synthetases |
| 02/01/2001 | CA2380270A1 26 human prostate and prostate cancer associated proteins |
| 02/01/2001 | CA2380226A1 Novel fibroblast growth factor and nucleic acids encoding same |
| 02/01/2001 | CA2380221A1 Monoterpene synthases from grand fir (abies grandis) |
| 02/01/2001 | CA2380192A1 Oligonucleotides for inhibiting the expression of human eg5 |
| 02/01/2001 | CA2380171A1 Transposon mediated differential hybridisation |
| 02/01/2001 | CA2379927A1 Integration of biochemical protocols in a continuous flow microfluidic device |
| 02/01/2001 | CA2379863A1 Kinase blocking polypeptides and uses thereof |
| 02/01/2001 | CA2379804A1 Dna ligase ii orthologue and uses thereof |
| 02/01/2001 | CA2379802A1 Drosophila recombination-associated protein and methods for use |
| 02/01/2001 | CA2379801A1 Receptors and associated proteins |
| 02/01/2001 | CA2379796A1 Pyrf gene and its use |
| 02/01/2001 | CA2379784A1 Cell cycle and proliferation proteins |
| 02/01/2001 | CA2379777A1 Isolated peptide of the horny layer and use thereof |
| 02/01/2001 | CA2379729A1 Protease conjugates having sterically protected clip sites |
| 02/01/2001 | CA2379712A1 Subtilisin protease variants having amino acid deletions and substitutions in defined epitope regions |
| 02/01/2001 | CA2379659A1 Antisense modulation of pten expression |
| 02/01/2001 | CA2379518A1 Electron donor system for enzymes and its use for the biochemical conversion of substrates |
| 02/01/2001 | CA2379400A1 Recombinant high molecular weight major outer membrane protein of moraxella |
| 02/01/2001 | CA2379251A1 Highly purified cytokine activating factor and methods of use |
| 02/01/2001 | CA2379237A1 Fragments of cellular prion protein and methods useful in the diagnosis and treatment of prion diseases |
| 02/01/2001 | CA2378953A1 Methods and compositions for inhibiting polypeptide accumulation associated with neurological disorders |
| 02/01/2001 | CA2378944A1 Method for rnase- and organic solvent-free plasmid dna purification using tangential flow filtration |
| 02/01/2001 | CA2378845A1 Vgf selective binding agents and methods of treating vgf-related disorders |
| 02/01/2001 | CA2378643A1 Muscle cells and their use in cardiac repair |
| 02/01/2001 | CA2378569A1 Method for relative quantization of methylation of cytosin-type bases in dna samples |
| 02/01/2001 | CA2378473A1 Modulation of platelet activation |
| 02/01/2001 | CA2378462A1 Ppar delta inhibitors for the treatment of cardiovascular diseases |
| 02/01/2001 | CA2378403A1 Novel polynucleotides and method for the use thereof |
| 02/01/2001 | CA2378110A1 Cell/tissue analysis via controlled electroporation |
| 02/01/2001 | CA2378107A1 <i>arabidopsis thaliana</i> cyclic nucleotide-gated ion channel/<i>dnd</i> genes; regulators of plant disease resistance and cell death |
| 02/01/2001 | CA2377810A1 Method for marking solid, liquid and gaseous substances |
| 02/01/2001 | CA2377693A1 Methods for producing l-amino acids |
| 02/01/2001 | CA2376045A1 Subtilisin protease variants having amino acid substitutions in defined epitope regions |
| 02/01/2001 | CA2375650A1 Ehrlichia canis genes and vaccines |
| 02/01/2001 | CA2375571A1 Human nervous system-associated proteins |
| 02/01/2001 | CA2371069A1 Means and methods for nucleic acid transfer |
| 02/01/2001 | CA2343714A1 Homeobox gene encoding a protein involved in differentiation |
| 01/31/2001 | EP1072688A1 Method for in vivo detecting target protein gene by drug |
| 01/31/2001 | EP1072687A2 Method for testing metastatic potential and method for screening compounds with metastasis-suppressing activity |
| 01/31/2001 | EP1072686A2 Method for 5'-cap dependant cDNA enrichment |
| 01/31/2001 | EP1072685A1 Gene of rice dihydrodipicolinate synthase and dna relating to the same |
| 01/31/2001 | EP1072684A1 Genes encoding proteins having activity of transferring sugar onto aurone |
| 01/31/2001 | EP1072683A1 Process for producing isoprenoid compounds by using microorganisms and method for detecting compounds having antibacterial or herbicidal activity |
| 01/31/2001 | EP1072682A1 Protein and gene participating in the differentiation of immortalized cells |
| 01/31/2001 | EP1072681A2 Human-keratinocytes regulator protein pKe#165 |
| 01/31/2001 | EP1072680A1 Myostatin regulatory region, nucleotide sequence determination and methods for its use |
| 01/31/2001 | EP1072678A1 Method for synthesizing dna |
| 01/31/2001 | EP1072677A1 Hybridoma cell line derived from 2.4G2 cell line, preferentially not expressing any mouse kappa chains |
| 01/31/2001 | EP1072611A1 Monoclonal antibody directed against the thrombin-antithrombin III complex and its use in immunoassays |
| 01/31/2001 | EP1072610A1 Novel cytokine-like protein |
| 01/31/2001 | EP1072010A2 Oligonucleotide mediated nucleic acid recombination |
| 01/31/2001 | EP1071959A2 Method for identifying chemical active agents and active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway |
| 01/31/2001 | EP1071957A1 Isolated nucleic acid molecule encoding cancer associated antigens, the antigens per se, and uses thereof |
| 01/31/2001 | EP1071955A1 Improved immunodiagnostic assays using reducing agents |
| 01/31/2001 | EP1071952A1 I kappa b and enhanced green fluorescent fusion protein |
| 01/31/2001 | EP1071827A1 Mixed cell diagnostic systems |
| 01/31/2001 | EP1071826A1 Identification of genetic targets for modulation by oligonucleotides and generation of oligonucleotides for gene modulation |
| 01/31/2001 | EP1071824A2 Quantitative analysis of gene expression |
| 01/31/2001 | EP1071823A2 Novel mutations in the (freac3 )gene for diagnosis and prognosis of glaucoma and anterior segment dysgenesis |
| 01/31/2001 | EP1071822A2 Fetal testing for prediction of low birth weight |
| 01/31/2001 | EP1071821A1 Methods for reducing non-specific binding to a nucleic acid probe array |
| 01/31/2001 | EP1071819A1 Recombinant proteins of treponema pallidum and their use for a syphilis vaccine |
| 01/31/2001 | EP1071816A1 Method for detecting allelic imbalance |
| 01/31/2001 | EP1071815A1 ASSAY FOR METHYLATION IN THE GST-Pi GENE |
| 01/31/2001 | EP1071814A1 Sequencing by hybridisation |
| 01/31/2001 | EP1071813A1 Tagged ligand arrays for identifying ligand-target interactions |
| 01/31/2001 | EP1071812A1 A method, reagent solution and kits for dna sequencing |
| 01/31/2001 | EP1071811A1 A method for the characterisation of nucleic acid molecules involving generation of extendible upstream dna fragments resulting from the cleavage of nucleic acid at an abasic site |
| 01/31/2001 | EP1071808A1 Telomerase assay of body fluids for cancer screening and assessment of disease stage and prognosis |
| 01/31/2001 | EP1071806A2 Materials and methods for gene therapy |
| 01/31/2001 | EP1071805A2 Adenoviral vectors for treating disease |
| 01/31/2001 | EP1071804A1 Use of triplex structure dna sequences for transferring nucleotide sequences |
| 01/31/2001 | EP1071803A1 Stress tolerant plants |
| 01/31/2001 | EP1071802A2 Carotenoid biosynthesis enzymes |
| 01/31/2001 | EP1071801A2 Carotenoid biosynthesis enzymes |
| 01/31/2001 | EP1071800A2 Carotenoid biosynthesis enzymes |
| 01/31/2001 | EP1071799A1 Seed specific polycomb group gene and methods of use for same |
| 01/31/2001 | EP1071798A1 Novel constructs for controlled expression of recombinant proteins in prokaryotic cells |
| 01/31/2001 | EP1071797A2 A method for isolating a polynucleotide of interest from the genome of a mycobacterium using a bac-based dna library. application to the detection of mycobacteria |
| 01/31/2001 | EP1071796A1 Regulable gene expression in gram-positive bacteria |
| 01/31/2001 | EP1071795A1 Canine erythropoietin gene and recombinant protein |
| 01/31/2001 | EP1071794A1 A method for inhibiting tumor invasion or spreading in a subject |
| 01/31/2001 | EP1071793A2 Tryptophan biosynthetic enzymes |
| 01/31/2001 | EP1071792A2 Human protease and use of such protease for pharmaceutical applications and for reducing the allergenicity of non-human proteins |
| 01/31/2001 | EP1071791A1 CLONING AND EXPRESSING THE ASPERGILLUS ORYZAE u BGII /u $g(b)-GLUCOSIDASE GENE |
| 01/31/2001 | EP1071790A1 Phytic acid biosynthetic enzymes |
| 01/31/2001 | EP1071789A1 Phytic acid biosynthetic enzymes |